These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22064348)

  • 1. AML1/ETO and POU4F1 synergy drives B-lymphoid gene expression typical of t(8;21) acute myeloid leukemia.
    Dunne J; Mannari D; Farzaneh T; Gessner A; van Delft FW; Heidenreich O; Young BD; Gascoyne DM
    Leukemia; 2012 May; 26(5):1131-5. PubMed ID: 22064348
    [No Abstract]   [Full Text] [Related]  

  • 2. AML1/ETO proteins control POU4F1/BRN3A expression and function in t(8;21) acute myeloid leukemia.
    Dunne J; Gascoyne DM; Lister TA; Brady HJ; Heidenreich O; Young BD
    Cancer Res; 2010 May; 70(10):3985-95. PubMed ID: 20460523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. POU4F1 is associated with t(8;21) acute myeloid leukemia and contributes directly to its unique transcriptional signature.
    Fortier JM; Payton JE; Cahan P; Ley TJ; Walter MJ; Graubert TA
    Leukemia; 2010 May; 24(5):950-7. PubMed ID: 20376082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JAK2 seems to be a typical cooperating mutation in therapy-related t(8;21)/ AML1-ETO-positive AML.
    Schnittger S; Bacher U; Kern W; Haferlach C; Haferlach T
    Leukemia; 2007 Jan; 21(1):183-4. PubMed ID: 17096014
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic significance of the AML1-ETO fusion transcript expression in children and young adults with t(8;21) acute myeloid leukemia.
    Fleischman EW; Baturina JA; Sokova OI; Popa AV; Kosorukova IS; Rowley JD
    Haematologica; 2003 Sep; 88(9):1078-9. PubMed ID: 12969821
    [No Abstract]   [Full Text] [Related]  

  • 6. Variant translocation t(2;21;8)(q36;q22;q22) with RUNX1/CBFA2T1 (AML1/ETO) transcript in a case of acute myelogenous leukemia.
    Hsiao HH; Sashida G; Kodama A; Fukutake K; Ohyashiki K
    Cancer Genet Cytogenet; 2005 May; 159(1):96-7. PubMed ID: 15860366
    [No Abstract]   [Full Text] [Related]  

  • 7. The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner.
    Elsässer A; Franzen M; Kohlmann A; Weisser M; Schnittger S; Schoch C; Reddy VA; Burel S; Zhang DE; Ueffing M; Tenen DG; Hiddemann W; Behre G
    Oncogene; 2003 Aug; 22(36):5646-57. PubMed ID: 12944913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.
    Yan M; Kanbe E; Peterson LF; Boyapati A; Miao Y; Wang Y; Chen IM; Chen Z; Rowley JD; Willman CL; Zhang DE
    Nat Med; 2006 Aug; 12(8):945-9. PubMed ID: 16892037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of AML1-ETO transcript expression in patients with acute myeloid leukemia and t(8;21) in complete hematologic remission.
    Buonamici S; Ottaviani E; Visani G; Bonifazi F; Fiacchini M; Baccarani M; Martinelli G
    Haematologica; 2004 Jan; 89(1):103-5. PubMed ID: 14754613
    [No Abstract]   [Full Text] [Related]  

  • 10. AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML.
    Licht JD
    Oncogene; 2001 Sep; 20(40):5660-79. PubMed ID: 11607817
    [No Abstract]   [Full Text] [Related]  

  • 11. The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia.
    Linggi B; Müller-Tidow C; van de Locht L; Hu M; Nip J; Serve H; Berdel WE; van der Reijden B; Quelle DE; Rowley JD; Cleveland J; Jansen JH; Pandolfi PP; Hiebert SW
    Nat Med; 2002 Jul; 8(7):743-50. PubMed ID: 12091906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel exon in AML1-ETO negatively influences the clonogenic potential of the t(8;21) in acute myeloid leukemia.
    Mannari D; Gascoyne D; Dunne J; Chaplin T; Young B
    Leukemia; 2010 Apr; 24(4):891-4. PubMed ID: 20111069
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular cytogenetic findings in a three-way novel variant of t(1;8;21)(p35;q22;q22): a unique relocation of the AML1/ETO fusion gene 1p35 in AML-M2.
    Ahmad F; Kokate P; Chheda P; Dalvi R; Das BR; Mandava S
    Cancer Genet Cytogenet; 2008 Jan; 180(2):153-7. PubMed ID: 18206543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular diversity in AML1/ETO fusion transcripts in patients with t(8;21) positive acute myeloid leukaemia.
    van de Locht LT; Smetsers TF; Wittebol S; Raymakers RA; Mensink EJ
    Leukemia; 1994 Oct; 8(10):1780-4. PubMed ID: 7523801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of AML1-ETO in t(8;21) leukemia by oridonin generates a tumor suppressor-like protein.
    Zhen T; Wu CF; Liu P; Wu HY; Zhou GB; Lu Y; Liu JX; Liang Y; Li KK; Wang YY; Xie YY; He MM; Cao HM; Zhang WN; Chen LM; Petrie K; Chen SJ; Chen Z
    Sci Transl Med; 2012 Mar; 4(127):127ra38. PubMed ID: 22461642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AML1-ETO9a is correlated with C-KIT overexpression/mutations and indicates poor disease outcome in t(8;21) acute myeloid leukemia-M2.
    Jiao B; Wu CF; Liang Y; Chen HM; Xiong SM; Chen B; Shi JY; Wang YY; Wang JH; Chen Y; Li JM; Gu LJ; Tang JY; Shen ZX; Gu BW; Zhao WL; Chen Z; Chen SJ
    Leukemia; 2009 Sep; 23(9):1598-604. PubMed ID: 19458628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel variant translocation t(6;8;21)(p22;q22;q22) leading to AML/ETO fusion in acute myeloid leukemia.
    Al Bahar S; Adriana Z; Pandita R
    Gulf J Oncolog; 2009 Jan; (5):56-9. PubMed ID: 20084788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duplication and triplication of der(21)t(8;21)(q22;q22) in acute myeloid leukemia.
    Mikulasovich M; LeBlanc A; Scalise A; Manwani D; Keyzner A; Najfeld V
    Cancer Genet Cytogenet; 2009 Jan; 188(2):83-7. PubMed ID: 19100510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of additional cytogenetic and molecular genetic abnormalities in acute myeloid leukaemia with t(8;21)/AML1-ETO.
    Kuchenbauer F; Schnittger S; Look T; Gilliland G; Tenen D; Haferlach T; Hiddemann W; Buske C; Schoch C
    Br J Haematol; 2006 Sep; 134(6):616-9. PubMed ID: 16938118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.